Puerto Rico May Restrict Medical Cannabis and Lose $53 Million a Year

There are advances that open pathways for those seeking relief and quality of life, but there are also decisions capable of closing doors. In Puerto Rico, a proposal to restrict medical cannabis is raising red flags: beyond hindering patient access to treatment, the measure could cause multimillion-dollar losses to public coffers.

According to Cañamo magazine, the Puerto Rico Legislative Assembly Budget Office estimates that public tax revenues could drop by up to $53 million per year if the most restrictive proposal is approved. The initiative is still under legislative review and could alter the access rules to the medical cannabis program.

In this article, you will see:

• What the proposal to restrict medical cannabis entails.
• Why Puerto Rico could lose up to $53 million per year.
• How the change could affect patients and public services.
• What this scenario reveals about medical cannabis policies.

Medical cannabis restriction could exclude patients

According to the report by Cañamo, the legislative proposal known as House Bill 1281 aims to modify the current rules of Puerto Rico's medical cannabis program. The initiative seeks to limit eligibility, restricting access primarily to individuals with terminal illnesses or debilitating conditions directly related to them.

The potential impact is significant. In the most restrictive scenario analyzed by the Legislative Assembly Budget Office, the number of people eligible to participate in the program could drop by up to 95%.

It is important to emphasize that this projection represents a hypothetical scenario considered in the report, rather than a confirmed reduction. Even so, the figure outlines the potential scope that a change in rules could have on patients and the regulated market.

For those who rely on medical supervision and individualized treatments, the debate extends beyond legislation. Defining who can access medical cannabis directly impacts the possibilities of continuing care.

LEARN MORE: What is the legal status of cannabis in Puerto Rico?

Medical cannabis in Puerto Rico could cost $53 million

The potential restriction also carries economic consequences. According to Cáñamo, the Budget Office's estimate points out that revenue losses could reach $53 million annually starting in fiscal year 2027, under the highest-impact scenario.

The projection accounts for the decline in revenues from sales and income taxes, as well as fees associated with licenses and other economic activities tied to the program.

A portion of these funds also contributes to financing specific public services. According to the data reported by the magazine, the Hospital de Trauma at the Centro Médico de Río Piedras could lose out on approximately $2.2 million per year. Meanwhile, the Fund for Catastrophic Illness Services could lose around $3.9 million in the most restrictive scenario.

These figures are estimates contingent upon the proposal's potential approval and its eventual effects. Even so, they show that decisions regarding access to medical cannabis are not limited to the relationship between patients and healthcare professionals: they can also impact the funding of public services.

LEARN MORE: Cannabis market in Latin America: 10 pioneering companies

While the world moves forward, access returns to the center of the debate

Puerto Rico's scenario exposes a significant contradiction. While different markets discuss ways to regulate cannabis and expand knowledge about its therapeutic applications, the island is evaluating a proposal that could drastically reduce the number of people eligible to participate in its medical program.

The debate also unfolds amid signs of strain within the system itself, such as a decline in the number of physicians authorized to monitor cannabis treatments, as noted by Cáñamo.

This does not mean that every expansion of access is automatically appropriate, nor does it eliminate the need for clinical criteria, professional oversight, and safety policies. However, any restrictive change must consider its consequences for patients and the care infrastructure.

When access to treatment is restricted, it is necessary to evaluate who will be affected, what alternatives will be available, and what the social and economic impacts of that decision will be.

What happens now with medical cannabis in Puerto Rico?

The proposal is still undergoing legislative review. Therefore, the possible effects described in the report depend on the progress of the legislation and the eventual approval of the changes.

For now, the estimate of up to $53 million in annual losses adds an economic dimension to the debate over the future of medical cannabis in Puerto Rico.

More than numbers, the discussion involves public policy choices that could determine who will have access to treatments, how resources will be allocated, and what role the regulated market will play in the healthcare system.

In health policy, rolling back access rules can have consequences that extend far beyond legislation. Therefore, following the proposal's legislative progress is essential to understanding what is at stake for patients, professionals, and Puerto Rican society.